Approval · Notice of Compliance 30082 · 2023
CLEVIPREX: Notice of Compliance 30082
Issued February 7, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30082
- Date
- February 7, 2023
- Company
- Chiesi Farmaceutici S.P.A.Parma, --, Italy
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional starting material manufacturing sites
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLEVIPREX | Not yet assigned | — |
Medicinal ingredients
- CLEVIDIPINE 0.5 MG per ML